Sunday, May 10, 2026 10:46:45 AM
Thank You for your response. Yes, we are seeing things differently. You believe LP was handling things with prudence. I believe it was more on the panic side. Something was amiss with LL not appearing, which should have been an indicator of something on the tracks ahead. Your version says LP warned the OTC market to keep an eye out for skullduggery and to halt stock so "she could create a record". You're saying she was proactive. I believe she was more reactive. No one knows exactly what was said and when it was said. I believe they saw the SP falling rapidly and didn't know what to do. There was no immediate action by the company, at least none that I know of. I'm not even sure what they could have done, but what they did do was go silent. After the debacle, the company said, and I remember this part, they were surprised at the attack and had to have meetings on what to do next. I believe DI said this, but I could be wrong.
Your statement " A company preparing to disclose highly material clinical trial results at a public scientific conference has every reason to think about market-order issues around that disclosure." illustrates my point, they were not prepared for such a big event.
I don't believe FEMikes full blown conspiracy theory. But I also don't buy they were prepared for the attack.
"And the data were not a failure.", we all know that. I never said it was. I was shocked as everyone else at the falling SP. I can see how the company was shocked as well, but I'm not going to revise history and claim they knew it was coming and prepared for it.
Your statement " A company preparing to disclose highly material clinical trial results at a public scientific conference has every reason to think about market-order issues around that disclosure." illustrates my point, they were not prepared for such a big event.
I don't believe FEMikes full blown conspiracy theory. But I also don't buy they were prepared for the attack.
"And the data were not a failure.", we all know that. I never said it was. I was shocked as everyone else at the falling SP. I can see how the company was shocked as well, but I'm not going to revise history and claim they knew it was coming and prepared for it.
Recent NWBO News
- How Advanced Drug Delivery Could Improve Existing Cancer Treatments • GlobeNewswire Inc. • 06/01/2026 12:30:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
